Terkko Navigator / Journal of Allergy and Clinical Immunology

Successful use of methylprednisolone for treating severe COVID-19

Update on JACI’S evolution

SARS-CoV-2 Antibody Testing – Questions to be asked

The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes

Reply

Does asthma affect morbidity or severity of Covid-19?

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

COVID19: Time to embrace MDI+ valved-holding chambers!

Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype

Accuracy of Penicillin Allergy Diagnostic Tests: A Systematic Review and Meta-analysis

Reply

IgG Fc sialylation is regulated during the germinal center reaction upon immunization with different adjuvants

Clinical Testing For Covid-19

Phenotypic and functional translation of IL33 genetics in asthma

Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype

POLYGENIC RISK SCORE FOR ATOPIC DERMATITIS IN THE CANADIAN POPULATION

NK cells as a possible new player in atopic dermatitis

Low-dose capsaicin (0.01 mM) nasal spray is equally effective as the current standard treatment for idiopathic rhinitis: a randomized, double-blind, placebo-controlled trial

Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19

Assessment of a causal relationship between body mass index and atopic dermatitis

Phase 2 Randomized, Double-blind Study of IL-17-Targeting with Secukinumab in Atopic Dermatitis

Protein functionality as a potential bottleneck for somatic revertant variants

Incidence of cancer after asthma development: two independent population-based cohort studies

Type 2 Inflammation Modulates ACE2 and TMPRSS2 in Airway Epithelial Cells

Perforin and resistance to SARS coronavirus 2

Type 2 Inflammation in Chronic Rhinosinusitis without Nasal Polyps: Another Relevant Endotype

COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab

COMPLEMENT ACTIVATION IN PATIENTS WITH COVID-19: A NOVEL THERAPEUTIC TAR

Glucocorticoids and the cytokines IL-12, IL-15 and IL-18 present in the tumor microenvironment induce PD-1 expression on human Natural Killer cells

Molecular Mechanism-driven New Biomarkers and Therapies for Atopic Dermatitis

IgG+ memory B cells: friends or foes in allergic disease?

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients - a perspective

The immunologic status of newborns born to SARS-CoV2-infected mothers in Wuhan, China

Midostaurin improves quality of life and mediator–related symptoms in advanced systemic mastocytosis

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease

Reply

COVID-19: unanswered questions on immune response and pathogenesis

Air pollution, racial disparities and COVID-19 mortality

Efficacy and safety of anti-CD45-Saporin as conditioning agent for RAG deficiency

Active control of mucosal tolerance and inflammation by human IgA and IgG antibodies

Editorial Board

Table of Contents

Brief Overview of This Month's JACI

Cover 1

HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency

Perspective: COVID-19, Implications of nasal diseases and consequences for their management

Reply

Cephalosporin allergens: Is the cephalosporoyl and R1 side-chain focus too narrow?

Reply

Anti–Saccharomyces cervisiae antibodies in hidradenitis suppurativa: More than a gut feeling